Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-09

Clinical Trial Update: A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BMS-986036 in obese adults with type 2 diabetes has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-986036

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2019-05-09